Women across the country are filing lawsuits against Pfizer, alleging that Depo-Provera causes meningiomas, a risk the company knew about and failed to disclose. Meningiomas are tumors that grow along the membranes surrounding the brain or spinal cord. While many are noncancerous, they can still cause serious harm, including vision loss, seizures, cognitive changes, and the need for surgery.

If you or someone you love used Depo-Provera and later received a meningioma diagnosis, understanding what these lawsuits allege and who may be affected is an important first step. The mass tort attorneys at Wagstaff & Cartmell are here to help guide you through this complicated and sometimes protracted process.

What Depo-Provera Is and How It Works as a Birth Control Shot

Depo-Provera is an injectable birth control method administered by a healthcare provider once every three months. It contains medroxyprogesterone acetate, a synthetic form of the hormone progesterone. The injection prevents pregnancy primarily by stopping ovulation and thickening cervical mucus to block sperm.

How the Contraceptive Injection Became Widely Used

Depo-Provera has been available in the United States since the FDA approved it for contraceptive use in 1992. Its convenience, particularly the fact that users do not need to take a daily pill, made it a popular choice for millions of women over the following decades. Pfizer manufactures and markets the drug.

Why Hormone Exposure Matters in a Depo-Provera Birth Control Lawsuit

Medroxyprogesterone acetate is a progestin, meaning it binds to hormone receptors throughout the body. Some meningioma brain tumors are known to have hormone receptors that can respond to progestins. This biological interaction is at the center of scientific and legal scrutiny surrounding long-term Depo-Provera use.

The Link Between Depo-Provera and Brain Tumors

Several studies published in recent years have examined the relationship between progestin-based contraceptives and meningioma development. Some of that research has found elevated rates of meningioma among women who used high-dose synthetic progestins, including medroxyprogesterone acetate, over extended periods. These findings have drawn attention from medical researchers and regulators who study injectable birth control and cancer risk.

Meningiomas form in the meninges, the protective layers of tissue that surround the brain and spinal cord. Although many meningiomas grow slowly and are classified as benign, their location can cause dangerous pressure on surrounding brain tissue. Symptoms can include persistent headaches, changes in vision, memory problems, and neurological deficits that affect daily functioning.

Regulatory agencies in France and other European countries have taken steps to restrict or warn about progestin-based medications in connection with increased risk of brain tumors. The evolving regulatory landscape has added weight to claims that manufacturers of these drugs, including Pfizer, had access to safety signals earlier than they disclosed to the public. Whether U.S. regulators will take similar action remains an open question in ongoing litigation.

The Lawsuits Against Pfizer Allege an Increased Meningioma Risk with Depo-Provera Use

The central allegation in most Depo-Provera lawsuits is that Pfizer failed to adequately warn patients and healthcare providers about the potentially higher risk of meningioma associated with long-term use. Plaintiffs argue that the drug’s labeling did not reflect available safety data about the connection between medroxyprogesterone acetate and tumor growth. These are alleged claims, and no court has issued a final ruling establishing this as proven fact.

Negligence and Product Liability

Many plaintiffs are also asserting claims based on negligence and product liability, arguing that Pfizer had a duty to monitor post-market safety data and act on warning signs. The lawsuits contend that the company prioritized sales over patient safety by failing to update its warnings or conduct adequate follow-up research. These allegations form the legal foundation of claims being filed in courts across the country.

What Plaintiffs Are Seeking

Women who have filed suit are seeking compensation for medical expenses related to meningioma diagnosis and treatment, which can include surgery, radiation, and long-term monitoring. Plaintiffs also seek damages for pain and suffering, lost income, and diminished quality of life. Some cases may also include claims for punitive damages if evidence supports allegations of knowing concealment.

Who May Be Affected

Women who used Depo-Provera for an extended period, generally two years or longer, appear to be the focus of most litigation because that duration of exposure is most often cited in the research being cited by plaintiffs. The concentration of progestin from repeated injections accumulates over time, which is why length of use is considered a relevant factor. If you received Depo-Provera injections over multiple years, your history of use is worth reviewing with an attorney.

Women Diagnosed With Meningiomas

A meningioma diagnosis following Depo-Provera use is the core injury alleged in these cases. Women who required surgery, radiation, or who are living with ongoing neurological symptoms may have the most direct connection to the claims being made in litigation. A prior Depo-Provera user who receives a meningioma diagnosis should carefully document her medical history, including all injection records and imaging results.

Those Who Did Not Receive Adequate Warnings

Even women who were not diagnosed with a meningioma but who used Depo-Provera extensively may have questions about their health and legal options. The failure-to-warn theory means that any patient who was denied the ability to make an informed decision about injectable birth control cancer risks may have grounds to consult with an attorney. Speaking with a legal team familiar with pharmaceutical mass tort litigation can help clarify whether your circumstances are relevant to these cases.

Frequently Asked Questions

These questions address common concerns women have when first learning about Depo-Provera and meningioma litigation. If your situation is not covered here, contacting an attorney is the most direct way to get answers tailored to your circumstances.

What Is a Meningioma, and Is It Always Cancerous?

A meningioma is a tumor that forms in the meninges, the tissue surrounding the brain and spinal cord. Most meningiomas are classified as benign, meaning they are not cancerous, but they can still cause serious health problems depending on their location and size. Treatment often involves surgery, radiation, or ongoing monitoring.

How Is Depo-Provera Causing Meningiomas Connected to Litigation?

Plaintiffs allege that the synthetic progestin in Depo-Provera may stimulate hormone receptors in meningioma tissue, contributing to tumor growth. Research from multiple countries has examined this potential link, though causation has not been legally established in U.S. courts. These lawsuits claim Pfizer knew or should have known about this risk and failed to warn users.

Who Manufactured Depo-Provera?

Pfizer manufactures and markets Depo-Provera in the United States. The lawsuits currently being filed name Pfizer as the defendant based on its role as the drug’s manufacturer and the party responsible for its labeling. Claims against Pfizer center on alleged failures in post-market safety surveillance and warning label updates.

How Long Did Someone Need to Use Depo-Provera to Be Eligible to File a Claim?

There is no universally fixed minimum, but most cases involve women who used the injectable birth control for two or more years. Duration of use is considered a relevant factor because longer exposure means more accumulated hormone concentration. An attorney can assess your specific history of use and whether it aligns with the profiles of plaintiffs currently in litigation.

Is There a Deadline to File a Lawsuit?

Yes. Personal injury claims are subject to statutes of limitations, which are legal deadlines for filing suit. These deadlines vary by state and by when the injury was discovered, so time is a genuine consideration. Consulting an attorney as early as possible helps ensure you do not lose the right to pursue a claim.

What Kinds of Damages Can Be Sought in These Cases?

Plaintiffs in Depo-Provera lawsuits are seeking compensation for medical costs, lost income, pain and suffering, and reduced quality of life. Some claims also include requests for punitive damages based on allegations of knowing concealment of risk. Every case is different, and the damages available depend on the specific facts of each individual claim.

Do I Need to Have Already Filed a Lawsuit to Talk to an Attorney?

No. An initial consultation with an attorney does not mean you have committed to filing a lawsuit. It is simply an opportunity to discuss your medical history, your use of injectable birth control, and whether the cancer or tumor risks alleged in this litigation may be relevant to your situation. Most mass tort attorneys offer consultations at no cost and no obligation.

Contact Our Attorneys for a Free Consultation on Your Depo-Provera Lawsuit

If you used Depo-Provera and have since been diagnosed with a meningioma, you deserve to understand your legal options. At Wagstaff & Cartmell, our attorneys represent individuals harmed by pharmaceutical products and are monitoring the developing litigation surrounding Depo-Provera and meningioma claims. We encourage you to reach out to our team to discuss your experience, review your medical history, and determine whether a claim may be appropriate for your circumstances. There is no cost to speak with us, and no obligation to move forward.